Omeros’ investigational new drug application for oms906 cleared by fda

Seattle--(business wire)--omeros corporation today announced that its investigational new drug application (ind) to begin clinical trials with oms906 has been cleared by the u.s. food and drug administration (fda).

OMER Ratings Summary

OMER Quant Ranking